Exagen News

Exagen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 13 09:34 ET

Exagen | 8-K: Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year

May 13 08:04 ET

Exagen | DEFA14A: Others

Apr 26 17:10 ET

Exagen | 8-K: Current report

Apr 26 08:34 ET

Exagen | DEF 14A: Definitive information statements

Apr 26 08:33 ET

Exagen | 8-K: Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

Mar 18 08:04 ET

Exagen | 8-K: Current report

Jan 8 00:00 ET

Exagen | 8-K: Current report

Dec 11, 2023 16:05 ET

Exagen | S-3/A: Registration statement for specified transactions by certain issuers (Amendment)

Nov 27, 2023 16:05 ET

Exagen | 8-K: Current report

Nov 17, 2023 16:30 ET

Exagen | S-3: Registration statement for specified transactions by certain issuers

Nov 17, 2023 16:06 ET

Exagen | 8-K: Exagen Inc. Reports Strong Third Quarter 2023 Results

Nov 13, 2023 16:05 ET

Exagen | 8-K: Current report

Oct 26, 2023 16:05 ET

Exagen | 8-K: Exagen Inc. Reports Strong Second Quarter 2023 Results

Aug 7, 2023 08:00 ET

Exagen | 8-K: Current report

Jul 24, 2023 16:05 ET

Exagen | 8-K: Current report

Jun 14, 2023 16:50 ET

Exagen | DEFA14A: Others

May 24, 2023 16:05 ET

Exagen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 18, 2023 16:06 ET

Exagen | 8-K: Exagen Inc. Reports First Quarter 2023 Results

May 15, 2023 16:05 ET

Exagen | 8-K: Current report

May 4, 2023 09:00 ET